NMAC Demands Immediate Action from Secretary Rubio on Lifesaving PEPFAR Concerns at Senate Oversight Hearing
WASHINGTON, DC, UNITED STATES, May 15, 2025 / EINPresswire.com / -- With millions of lives at stake and the Senate about to hold a critical oversight hearing, NMAC is calling on Secretary Marco Rubio to provide direct, immediate answers regarding the future of the President's Emergency Plan for AIDS Relief (PEPFAR) program. PEPFAR is one of the most successful life-saving humanitarian efforts ever undertaken by the United States, having saved over 26 million lives and transformed the global fight against HIV/AIDS. The decisions made now will determine whether essential HIV treatment and prevention services continue—or collapse—in vulnerable communities worldwide.
'For the millions who rely on PEPFAR, delays in treatment aren't just bureaucratic hurdles—they are life-threatening,' said Joe Huang-Racalto, Director of Strategic Partnerships and Policy at NMAC. 'This hearing must address the urgent gaps threatening the most vulnerable, especially children.'
Swift and transparent responses to two pressing questions are urgently needed:
Unspent PEPFAR Funds at USAID:
Existing PEPFAR funds remain stuck at USAID, unable to transfer to CDC, the Department of Defense, and other agencies responsible for administering the PEPFAR program to deliver lifesaving HIV treatment and care. Without immediate action, lifesaving HIV treatment services will be lost until at least September—a devastating failure that undermines the intent of the Waiver Authority.
What urgent steps will the administration take to free these resources now? How can Congress, the administration, and stakeholders collaborate to prevent unnecessary suffering? Additionally, what percentage of HIV treatment services in 2024 were managed by the CDC?
Expanding the Waiver to Protect Vulnerable Children:
Children at risk of acquiring and or living with HIV in PEPFAR supported countries cannot afford delays.
Will Secretary Rubio support expanding the current waiver to include Prevention of Mother-to-Child Transmission services and other essential HIV prevention programs?
Even a narrowly tailored expansion—focused on stabilizing regions with rising HIV cases—would continue to prevent unnecessary infections, save lives, and safeguard critical prevention efforts.
'These are not theoretical debates,' Huang-Racalto emphasized. 'We are already hearing from field partners about suspended services that are leaving communities exposed. Secretary Rubio must provide clarity on the administration's plan and commit to preventing irreversible harm.'
NMAC urges Secretary Rubio to act decisively and transparently. The time for vague assurances is over—PEPFAR's legacy depends on protecting those most at risk, now.
NMAC Press Contact:
Pavni Guharoy
Director of Communications
[email protected]
240 372 8394
Pavni Guharoy
NMAC
+1 240-372-8394
email us here
Visit us on social media:
LinkedIn
Instagram
YouTube
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
37 minutes ago
- Associated Press
Israeli-backed group seeks at least $30 million from US for aid distribution in Gaza
WASHINGTON (AP) — A U.S.-led group has asked the Trump administration to step in with an initial $30 million so it can continue its much scrutinized and Israeli-backed aid distribution in Gaza, according to three U.S. officials and the organization's application for the money. That application, obtained by The Associated Press, also offers some of the first financial details about the Gaza Humanitarian Foundation and its work in the territory. The foundation says it has provided millions of meals in southern Gaza since late May to Palestinians as Israel's blockade and military campaign have driven the Gaza to the brink of famine. But the effort has seen near-daily fatal shootings of Palestinians trying to reach the distribution sites. Major humanitarian groups also accuse the foundation of cooperating with Israel's objectives in the 20-month-old war against Hamas in a way that violates humanitarian principles. The group's funding application was submitted to the U.S. Agency for International Development, according to the U.S. officials, who were not authorized to discuss the matter publicly and spoke on condition of anonymity. The application was being processed this week as potentially one of the agency's last acts before the Republican administration absorbs USAID into the State Department as part of deep cuts in foreign assistance. Two of the officials said they were told the administration has decided to award the money. They said the processing was moving forward with little of the review and auditing normally required before Washington makes foreign assistance grants to an organization. In a letter submitted Thursday as part of the application, Gaza Humanitarian Foundation secretary Loik Henderson said his organization 'was grateful for the opportunity to partner with you to sustain and scale life-saving operations in Gaza.' Neither the State Department nor Henderson immediately responded to requests for comment Saturday. Israel says the foundation is the linchpin of a new aid system to wrest control from the United Nations, which Israel alleges has been infiltrated by Hamas, and other humanitarian groups. The foundation's use of fixed sites in southern Gaza is in line with Israeli Prime Minister Benjamin Netanyahu's plan to use aid to concentrate the territory's more than 2 million people in the south, freeing Israel to fight Hamas elsewhere. Aid workers fear it's a step toward another of Netanyahu's public goals, removing Palestinians from Gaza in 'voluntary' migrations that aid groups and human rights organizations say would amount to coerced departures. The U.N. and many leading nonprofit groups accuse the foundation of stepping into aid distribution with little transparency or humanitarian experience, and, crucially, without a commitment to the principles of neutrality and operational independence in war zones. Since the organization started operations, several hundred Palestinians have been killed and hundreds more wounded in near-daily shootings as they tried to reach aid sites, according to Gaza's Health Ministry. Witnesses say Israeli troops regularly fire heavy barrages toward the crowds in an attempt to control them. The Israeli military has denied firing on civilians. It says it fired warning shots in several instance, and fired directly at a few 'suspects' who ignored warnings and approached its forces. It's unclear who is funding the new operation in Gaza. No donor has come forward. The State Department said this past week that the United States is not funding it. In documents supporting its application, the group said it received nearly $119 million for May operations from 'other government donors,' but gives no details. It expects $38 million from those unspecific government donors for June, in addition to the hoped-for $30 million from the United States. The application shows no funding from private philanthropy or any other source. ___ AP Diplomatic Writer Matthew Lee contributed to this report.
UPI
an hour ago
- UPI
NIH office to phase out HIV guidelines by next year
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. File Photo by Annabelle Gordon/UPI | License Photo June 21 (UPI) -- The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS patients in the United States is making major changes. The NIH Office of AIDS Research or OAR told its employees this week it intends to phase out the guidelines by next June, the Washington Post reported, citing an internal staff email. According to the office, OAR "coordinates HIV/AIDS research across the National Institutes of Health and provides the largest public investment in HIV/AIDS research globally." "In the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within" the letter obtained by The Post reads. The OAR guidelines contain guidelines related to diagnosis and treatments of HIV and AIDS. There are currently more than 1 million people living with HIV in the United States. It was not immediately clear what the other agency referred to in the letter was or how such a move may affect the guideline, the Post reported. The news comes as President Donald Trump and Secretary of State Marco Rubio move to cut over $8 billion from the U.S. Agency for International Development, USAID and merge it into the State Department. State Department officials say the move comes with the expectation that other countries will increase their roles in delivering aid around the world. An April report published in the Lancet medical journal found around half a million children globally could die from AIDS by 2030 if the United States cuts its global relief funding. Earlier this week, the U.S. Food and Drug Administration approved use of the HIV drug lenacapavir, which is produced by California-based biopharma firm Gilead Sciences under the name Yeztugo. "Yeztugo is one of the most important scientific breakthroughs of our time and offers a very real opportunity to help end the HIV epidemic," Gilead Science Chairman and Chief Executive Officer Daniel O'Day said in a statement on the company's website
Washington Post
9 hours ago
- Washington Post
Administration to phase out NIH support of HIV clinical guidelines
The National Institutes of Health's support for federal guidelines that steer the treatment of more than a million HIV patients in the United States will be phased out by next June, according to the agency's Office of AIDS Research, a move that troubled some doctors and raised questions about whether the guidelines themselves will change. It is unclear whether Health and Human Services Secretary Robert F. Kennedy Jr. plans to bring the guidance in line with his own controversial views about an infectious disease that 30 years ago was the leading cause of death for people 25 to 44 years old. The Office of AIDS Research, which is part of the National Institutes of Health, informed members of the panels responsible for the guidelines in a letter that, 'in the climate of budget decreases and revised priorities, OAR is beginning to explore options to transfer management of the guidelines to another agency within' HHS. The guidelines, detailed recommendations on how to diagnose and treat medical conditions, can affect what tests, treatments and medications are covered by insurance companies and Medicare, said Aniruddha Hazra, associate professor of medicine at University of Chicago Medicine. The lack of clarity in the letter caused some in the medical community to worry that switching oversight of the guidelines to another branch of HHS could be a first step by the Trump administration toward more drastic changes in the government's treatment recommendations. 'From a practical standpoint, it's monumental,' Hazra said of the news about the guidelines, which he called the basis for much of the knowledge about HIV. 'The loss of this kind of federal guidance throws everything into the dark,' he said. Hazra described the guidelines as a dynamic document that changes at least once or twice a year as new studies and scientific evidence come to light. Guidelines for HIV are divided into a half-dozen categories, including sets for adults/adolescents, pediatric patients, pregnant women and HIV patients who are displaced by natural disasters. The webpage listing the guidelines now says they are 'being updated to comply with Executive Orders,' raising the question of whether sections dealing with care for transgender people with HIV may be changed or eliminated. The letter sent to panel members did not say specifically if or how the clinical practice guidelines might change, only that 'Together, we now have an opportunity to develop a proactive, careful transition plan for each Panel.' The letter noted that 'a special session on guidelines sustainability planning' has been scheduled for Thursday with panel leadership and the Office of AIDS Research Advisory Council. Officials at NIH referred questions to the Department of Health and Human Services, which did not respond to emails requesting clarification of the letter. Kennedy has long espoused controversial views about HIV, suggesting that contrary to widely held medical belief, the virus was not the cause of AIDS. In a video posted on Twitter in 2023, Kennedy tells an audience, 'A hundred percent of the people who died at first, the first thousand who had AIDS, were people who were addicted to [a class of drugs called] poppers. … They were people who were part of a gay lifestyle. They were burning the candle at both ends, and they were taking a lot of injectable drugs.' Under Kennedy, HHS has terminated hundreds of millions of dollars in HIV-related research grants. The department closed its Office of Infectious Diseases & HIV Policy that coordinated the federal response to the virus. At the same time, the Centers for Disease Control and Prevention lost staff in its HIV prevention division who conducted studies and surveillance, ran health campaigns and supported local prevention programs. 'These guidelines serve as a reference for the world in addition to caring for people in the U.S.,' said Theodore Ruel, chief of the Division of Pediatric Infectious Diseases and Global Health at UCSF Benioff Children's Hospital, and co-chair of one of the panels responsible for the guidelines. 'It is disappointing that such a key guideline about HIV for children in the USA will no longer be supported by the NIH,' said Ruel — whose panel examines antiretroviral therapy for the medical management of children living with HIV — stressing that he was not speaking for the other panelists. 'I am concerned that we are unlikely to find a new home that can maintain the same depth, quality, access and capacity for real-time updating.' He expressed faith that the panelists would push to find a home for the guidelines where they can continue to offer 'science-driven support' for doctors and patients. James M. Sosman, medical director for UW Health's HIV Care and Prevention Program, who has been caring for people with the disease for decades, said that having the guidelines under the auspices of the Office of AIDS Research made sense. 'Would I look to move that? I'm reluctant because it's like, 'Hey, if you've got a guy that's hitting home runs at third base, don't move them to first base,'' Sosman said. 'I mean if it's working out, why are you disrupting this for costs that don't seem that great.'
